Literature DB >> 7628515

Skeletal muscle and the control of ventilation on exercise: evidence for metabolic receptors.

A L Clark1, M Piepoli, A J Coats.   

Abstract

Patients with chronic heart failure have an increased ventilatory response to exercise, and have metabolically abnormal skeletal muscle. It has been proposed that a neural signal to ventilation arising from exercising muscle may be heightened in chronic heart failure. Our objective was to detect evidence for such a signal in normal subjects by studying ventilatory behaviour during exercise with muscles in different metabolic states. Fifteen normal subjects undertook treadmill exercise both with and without cuffs inflated around each thigh to suprasystolic pressure. In a second experiment, a group of 11 normal subjects undertook cycle exercise using arms or legs at the same absolute work load. Metabolic gas exchange was measured using mass spectrometry with indicator gas dilution. The ventilatory response was greater at a given workload when subjects exercised with inflated cuffs. Oxygen consumption was reduced in keeping with the isolation of the exercising muscle bulk from the circulation. The ventilation/carbon dioxide output relationship was described by a linear regression function, but the slope of the relationship was increased by 25% from 20.9 (0.46) to 25.43 (0.73) (P < 0.001). Arm exercise at the same load as leg exercise resulted in unchanged oxygen consumption indicating that the same external work was being performed. There was an increase in ventilation at a given workload. The ventilation/carbon dioxide output slope was increased by 25% (from 21.9 (0.9) to 26.3 (0.8)) (P < 0.001). There is a signal to ventilation arising from exercising skeletal muscle which is enhanced by the ischaemia induced by cuff inflation during exercise. This signal appears to be neural.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7628515     DOI: 10.1111/j.1365-2362.1995.tb01705.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  14 in total

Review 1.  Origin of symptoms in chronic heart failure.

Authors:  A L Clark
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

2.  Cycle exercise causes a lower ventilatory response to exercise in chronic heart failure.

Authors:  K K A Witte; A L Clark
Journal:  Heart       Date:  2005-02       Impact factor: 5.994

Review 3.  [Acute dyspnoea].

Authors:  U Wagner; C Vogelmeier
Journal:  Internist (Berl)       Date:  2005-09       Impact factor: 0.743

4.  Relationship between exercise hyperpnea, hemodynamics, and blood gases before and during glyceryl trinitrate infusion in patients with exercise-induced elevation of pulmonary artery wedge pressure.

Authors:  L H Jørgensen; E Thaulow; H E Refsum
Journal:  Clin Cardiol       Date:  1997-09       Impact factor: 2.882

Review 5.  Pulmonary Limitations in Heart Failure.

Authors:  Ivan Cundrle; Lyle J Olson; Bruce D Johnson
Journal:  Clin Chest Med       Date:  2019-06       Impact factor: 2.878

6.  Abnormalities of skeletal muscle metabolism in patients with chronic heart failure: evidence that they are present at rest.

Authors:  R Andrews; J T Walsh; A Evans; S Curtis; A J Cowley
Journal:  Heart       Date:  1997-02       Impact factor: 5.994

7.  Contribution of skeletal muscle 'ergoreceptors' in the human leg to respiratory control in chronic heart failure.

Authors:  A C Scott; D P Francis; L C Davies; P Ponikowski; A J Coats; M F Piepoli
Journal:  J Physiol       Date:  2000-12-15       Impact factor: 5.182

Review 8.  The control of adrenergic function in heart failure: therapeutic intervention.

Authors:  A L Clark; J G Cleland
Journal:  Heart Fail Rev       Date:  2000-03       Impact factor: 4.214

Review 9.  [Heart and lungs : cardinal symptom dyspnea].

Authors:  M O Henke; C F Vogelmeier
Journal:  Herz       Date:  2013-05       Impact factor: 1.443

Review 10.  Exercise training in pulmonary arterial hypertension.

Authors:  Laura Adelaide Dalla Vecchia; Maurizio Bussotti
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.